Related Experiment Video
Updated: May 20, 2025

Disrupting Reconsolidation of Fear Memory in Humans by a Noradrenergic β-Blocker
Published on: December 18, 2014
Noradrenaline Synergistically Enhances Porphyromonas gingivalis LPS and OMV-Induced Interleukin-1β Production in BV-2
Sakura Muramoto1, Sachi Shimizu1, Sumika Shirakawa1
1School of Pharmacy, Yasuda Women's University, Hiroshima 731-0153, Japan.
Abstract:
Infection with Porphyromonas gingivalis (Pg), which is a major periodontal pathogen, causes a large number of systemic diseases based on chronic inflammation such as diabetes and Alzheimer's disease (AD). However, it is not yet fully understood how Pg can augment local systemic immune and inflammatory responses during progression of AD. There is a strong association between depression and elevated levels of inflammation. Noradrenaline (NA) is a key neurotransmitter that modulates microglial activation during stress conditions. In this study, we have thus investigated the regulatory mechanisms of NA on the production of interleukin-1β (IL-1β) by microglia following stimulation with Pg virulence factors, lipopolysaccharide (LPS), and outer membrane vesicles (OMVs). NA (30-1000 nM) significantly enhanced the mRNA level, promoter activity, and protein level of IL-1β up to 20-fold in BV-2 microglia following treatment with Pg LPS (10 μg/mL) and OMVs (150 μg of protein/mL) in a dose-dependent manner. Pharmacological studies have suggested that NA synergistically augments the responses induced by Pg LPS and OMVs through different mechanisms. AP-1 is activated by the β2 adrenergic receptor (Aβ2R)-mediated pathway. NF-κB, which is activated by the Pg LPS/toll-like receptor 2-mediated pathway, is required for the synergistic effect of NA on the Pg LPS-induced IL-1β production by BV-2 microglia. Co-immunoprecipitation combined with Western blotting and the structural models generated by AlphaFold2 suggested that cross-coupling of NF-κB p65 and AP-1 c-Fos transcription factors enhances the binding of NF-κB p65 to the IκB site, resulting in the synergistic augmentation of the IL-1β promoter activity. In contrast, OMVs were phagocytosed by BV-2 microglia and then activated the TLR9/p52/RelB-mediated pathway. The Aβ2R/Epac-mediated pathway, which promotes phagosome maturation, may be responsible for the synergistic effect of NA on the OMV-induced production of IL-1β in BV-2 microglia. Our study provides the first evidence that NA synergistically enhances the production of IL-1β in response to Pg LPS and OMVs through distinct mechanisms.
Insights
Noradrenaline (NA) amplifies interleukin-1 beta (IL-1β) production by microglia in response to Porphyromonas gingivalis (Pg) virulence factors. This study reveals distinct NA-mediated pathways that enhance inflammation, potentially impacting Alzheimer's disease progression.
Area of Science:
- Neuroimmunology
- Microbiology
- Molecular Biology
Background:
- Porphyromonas gingivalis (Pg) infection is linked to systemic diseases like Alzheimer's disease (AD) and inflammation.
- Noradrenaline (NA), a neurotransmitter, modulates microglial activation during stress, but its role in Pg-induced inflammation is unclear.
Purpose of the Study:
- To investigate how NA regulates interleukin-1 beta (IL-1β) production by microglia stimulated with Pg virulence factors (LPS and OMVs).
Main Methods:
- Utilized BV-2 microglia cell line stimulated with Pg LPS and OMVs.
- Measured IL-1β mRNA, promoter activity, and protein levels.
- Employed pharmacological inhibitors and co-immunoprecipitation.
- Applied AlphaFold2 for structural modeling.
Main Results:
- NA dose-dependently enhanced IL-1β production up to 20-fold.
- NA synergistically augmented Pg LPS-induced IL-1β via the β2 adrenergic receptor (Aβ2R)/AP-1 and TLR2/NF-κB pathways.
- Cross-coupling of NF-κB p65 and AP-1 c-Fos enhanced IL-1β promoter activity.
- NA synergistically enhanced OMV-induced IL-1β via the Aβ2R/Epac pathway, promoting phagosome maturation.
Conclusions:
- NA synergistically enhances microglial IL-1β production in response to Pg LPS and OMVs through distinct molecular mechanisms.
- Findings elucidate novel neuroinflammatory pathways relevant to AD pathogenesis and Pg infection.
Related Concept Videos
Adrenergic Agonists: Therapeutic Uses
Emergency and Intensive Care Unit (ICU) applications: Pressor agents increase blood pressure, heart rate, and contractility in shock and organ failure situations. Dopamine can induce vasodilation and stimulate adrenoceptors. Endogenous catecholamines are effective in treating cardiogenic shock. α2-agonists like clonidine can reverse anesthesia-induced hypertension.
Allergies and...
Adrenergic Agonists: Direct-Acting Agents
These agents can be classified...
Adrenergic Agonists: Indirect-Acting Agents
One mechanism involves depleting stored catecholamines by displacing them from synaptic vesicles. These agents, known as "displacers," are transported into vesicles at the expense of noradrenaline. Examples include amphetamine and tyramine, which lack a catechol moiety, resulting in prolonged action, improved oral...
Adrenergic Agonists: Mixed-Action Agents
Ephedrine and pseudoephedrine lack a catecholamine group, making them less susceptible to degradation by metabolic enzymes. They have increased oral bioavailability and lipophilicity, resulting in a longer duration of action. Their response is reduced by...
Adrenergic Neurons: Neurotransmission
Synthesis: Catecholamine synthesis requires tyrosine, which...
Adrenergic Receptors: β Subtype
Isoprenaline > Adrenaline > Noradrenaline
Neurotransmitter binding to these receptors causes activation of adenylyl cyclase resulting in increased concentrations of cAMP and modulation of calcium ion channels within the cell. They are further classified into β1, β2, and β3 subtypes.
β1-adrenoceptors: β1-adrenoceptors...

